P-wave duration and dispersion in patients with metabolic syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 9, 2009, Pages 1168-1172

  Yasar, Ayse Saatci ^a,b   Bilen, Emine ^a   Bilge, Mehmet ^a   Ipek, Gokturk ^a   Ipek, Emrah ^a   Kirbas, Ozgur ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b TSK Rehabilitasyon Merkezi   (Turkey)

Author keywords

Metabolic syndrome; P wave dispersion

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; P WAVE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 69849107347     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02460.x     Document Type: Article

References (28)

1. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999 159 : 1104 1109.
2. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999 83 : 25F 29F.
3. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
4. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 288 : 2709 2716.
5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001 24 : 683 689.
6. Dilaveris PE, Gialafos EJ, Sideris S, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998 135 : 733 738.
7. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K, Gialafos JE. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 2000 23 : 352 358.
8. Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunc K, Acil T, et al. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000 23 : 1109 1112.
9. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983 106 : 389 396.
10. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation: The Niigata Preventive medicine study. Circulation 2008 117 1255 1260.
11. Umetani K, Kdama Y, Nakamura T, Mende A, Kitta Y, Kawabata K, Obata J, et al. High prevalance of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Circ J 2007 71 : 252 255.
12. Ciaroni S, Cuenoud L, Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension. Am Heart J 2000 139 : 814 819.
13. Yazici M, Ozdemir K, Altunkeser BB, Kayrak M, Duzenli A, Vatankulu A, Soylu A, et al. The effect of diabetes mellitus on the P-wave dispersion. Circ J 2007 71 : 880 883.
14. Kosar F, Aksoy Y, Ari F, Keskin L, Sahin I. P-Wave duration and dispersion obese subjects. Ann Noninvasive Electrocardiol 2008 13 : 3 7.
15. Echahidi N, Mohty D, Pibarot P, Despres JP, O'Hara G, Champagne J, Philippon F, et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2007 116 (11 Suppl. I213 I219.
16. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 2002 54 : 230 246.
17. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW. C-reactive protein, the metabolic syndrome and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004 110 : 380 385.
18. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004 89 : 4963 4971.
19. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling: The potential role of inflammation and oxidative stress. Med Sci Monit. 2003 9 : RA225 RA229.
20. Nicolaou VN, Papadakis JE, Karatzis EN, Dermatitzaki SI, Tsakiris AK, Skoufas PD. Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation. Angiology 2007 58 : 21 25.
21. Chang SL, Tuan TC, Tai CT, Lin YJ, Lo LW, Hu YF, Tsao HM, et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am J Cardiol 2009 103 : 67 72.
22. de las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ, Davila-Roman VG. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J. 2007 28 : 553 559.
23. Masugata H, Senda S, Goda F, Yoshihara Y, Yoshikawa K, Fujita N, Daikuhara H, et al. Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res. 2006 29 : 897 903.
24. Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, Tamer A, Uyan C. The relationship between P-wave dispersion and diastolic dysfunction. Tex Heart Inst J 2005 32 : 163 167.
25. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005 48 : 1359 1365.
26. Brunner EJ, Heminway H, Walker BR, Page M, Clarke P, Juneja M, Shipley MJ, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation 2002 106 : 2659 2665.
27. Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ. Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 1995 26 : 497 502.
28. Tukek T, Akaya V, Demirel S, Sozen AB, Kudat H, Atilgan D, Ozcan M, et al. Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 2000 85 : 896 899.